SEC Form 4 · accession 0001179110-18-009007
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Minogue
Officer — Chairman, President, CEO · Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 par valueF5 | Jun 21, 2018 | M | 105,000 | $10.03 | A | 481,150 | D | |
| Common Stock $.01 par valueF6,F7 | Jun 21, 2018 | S | 2,400 | $434.4738 | D | 478,750 | D | |
| Common Stock $.01 par valueF6,F8 | Jun 21, 2018 | S | 7,984 | $435.6334 | D | 470,766 | D | |
| Common Stock $.01 par valueF6,F9 | Jun 21, 2018 | S | 5,481 | $436.7592 | D | 465,285 | D | |
| Common Stock $.01 par valueF6,F10 | Jun 21, 2018 | S | 8,009 | $437.884 | D | 457,276 | D | |
| Common Stock $.01 par valueF6,F11 | Jun 21, 2018 | S | 30,611 | $438.6508 | D | 426,655 | D | |
| Common Stock $.01 par valueF6,F12 | Jun 21, 2018 | S | 24,497 | $439.7387 | D | 402,168 | D | |
| Common Stock $.01 par valueF6,F13 | Jun 21, 2018 | S | 6,696 | $440.6038 | D | 395,472 | D | |
| Common Stock $.01 par valueF6,F14 | Jun 21, 2018 | S | 3,634 | $441.7512 | D | 391,838 | D | |
| Common Stock $.01 par valueF6,F15 | Jun 21, 2018 | S | 1,293 | $442.7477 | D | 390,545 | D | |
| Common Stock $.01 par valueF6,F16 | Jun 21, 2018 | S | 3,300 | $443.7724 | D | 387,245 | D | |
| Common Stock $.01 par valueF6,F17 | Jun 21, 2018 | S | 4,325 | $445.1681 | D | 382,920 | D | |
| Common Stock $.01 par valueF6,F18 | Jun 21, 2018 | S | 1,605 | $445.9237 | D | 381,315 | D | |
| Common Stock $.01 par valueF6,F19 | Jun 21, 2018 | S | 4,165 | $447.0059 | D | 377,150 | D | |
| Common Stock $.01 par valueF6 | Jun 21, 2018 | S | 1,000 | $450.06 | D | 376,150 | D | |
| Common Stock $.01 par value | holding | — | — | — | 46,654 | I | By Trust - A | |
| Common Stock $.01 par value | holding | — | — | — | 73,745 | I | By Trust - B | |
| Common Stock $.01 par value | holding | — | — | — | 9,000 | I | By Trust - C | |
| Common Stock $.01 par value | holding | — | — | — | 655 | I | By Trust - D | |
| Common Stock $.01 par value | holding | — | — | — | 38,560 | I | By Trust - E |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F5,F1 | $10.03 | Jun 21, 2018 | M | 105,000 | D | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 105,000 | 0 | D |
| Stock Option (Right to Buy)F2,F1 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 100,000 | D |
| Stock Option (Right to Buy)F2,F1 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2024 | Common stock | 0 | 85,000 | D |
| Stock Option (right to buy)F2,F3 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 85,000 | D |
| Stock Option (right to buy)F2,F3 | $66.25 | holding | — | — | — | May 13, 2016 | May 13, 2025 | Common Stock | 0 | 35,000 | D |
| Stock Option (right to buy)F4,F3 | $99.62 | holding | — | — | — | May 24, 2017 | May 24, 2026 | Common Stock | 0 | 30,500 | D |
| Stock Option (right to buy)F4,F3 | $134.51 | holding | — | — | — | May 15, 2018 | May 15, 2027 | Common Stock | 0 | 33,000 | D |
| Stock Option (right to buy)F4,F3 | $381.97 | holding | — | — | — | May 16, 2019 | May 16, 2028 | Common Stock | 0 | 30,000 | D |
Explanation of responses
- F1These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F10This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $437.1900 and $438.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F11This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $438.1700 and $439.1400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F12This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $439.1700 and $440.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F13This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $440.1700 and $441.0800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F14This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $441.1800 and $442.1500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F15This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $442.3700 and $442.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F16This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $443.4300 and $444.0700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F17This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $444.5400 and $445.5100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F18This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $445.6700 and $446.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F19This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $446.8300 and $447.2800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F4Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- F5Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
- F6Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $434.0900 and $435.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $435.1400 and $436.0400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $436.1800 and $437.1700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.